Activated Factor X Signaling Pathway via Protease-Activated Receptor 2 Is a Novel Therapeutic Target for Preventing Atrial Fibrillation-Reference-Cited by-同舟云学术

Activated Factor X Signaling Pathway via Protease-Activated Receptor 2 Is a Novel Therapeutic Target for Preventing Atrial Fibrillation

Published:2021-07-21 Issue:8 Volume:85 Page:1383-1391
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Matsuura Tomomi¹,Soeki Takeshi¹,Fukuda Daiju²,Uematsu Etsuko¹,Tobiume Takeshi¹,Hara Tomoya³,Kusunose Kenya¹,Ise Takayuki¹,Yamaguchi Koji¹,Yagi Shusuke¹,Yamada Hirotsugu¹,Wakatsuki Tetsuzo¹,Sata Masataka¹

Affiliation:

1. Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences

2. Department of Cardio-Diabetes Medicine, Tokushima University Graduate School of Biomedical Sciences

3. Department of Cardiovascular Medicine, Shikoku Medical Center for Children and Adults

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/85/8/85_CJ-20-1006/_pdf

Reference40 articles.

1. 1. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham Study. JAMA 1985; 254: 3449–3453.

2. 2. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998; 98: 946–952.

3. 3. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, et al. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886–2891.

4. 4. Engelmann MD, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005; 26: 2083–2092.

5. 5. Borissoff JI, Spronk HM, ten Cate H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med 2011; 364: 1746–1760.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling;International Journal of Molecular Sciences;2024-08-10

2. Risk Factors for Treatment Transition in Patients with Low-Risk Atrial Fibrillation Patients Undergoing Anticoagulation Monotherapy: A Large Claims Database Study in Japan;Biological and Pharmaceutical Bulletin;2024-07-31

3. Protease-activated receptor 2 at the intersection of thrombo-inflammation and beyond;IJC Heart & Vasculature;2024-06

4. Emerging roles of protease-activated receptors in cardiometabolic disorders;Journal of Cardiology;2023-04

5. Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?;Bleeding, Thrombosis, and Vascular Biology;2022-12-14